Microtuble-associated protein 2 (MAP2) is a protein that plays a crucial role in the regulation of microtubule dynamics and interactions, essential in neurogenesis. Biosensis’s validated MAP2 antibodies are designed to help users identify MAP2, whether they are detecting MAP2a, MAP2b or the distinctive MAP2c variant.
The company’s antibodies for MAP2 variants include antibodies that specifically target MAP2a and MAP2b, demonstrating high performance in western blots, as well as antibodies that identify all four MAP2 variants. They are distributed in Australia and New Zealand by Sapphire Bioscience.
Phone: 02 9698 2022
EpigenTek EpiQuik CUT&RUN m6A RNA Enrichment (MeRIP) Kit
The kit is a complete set of optimised buffers and reagents designed to enrich an RNA fragment...
Cayman Chemical Off-Patent Drug Screening Library (96-Well)
Featuring a curated collection of FDA-approved compounds that are no longer covered under...
Norgen Biotek Bacterial EV Isolation Kit
The Bacterial EV Isolation Kit enables researchers to isolate extracellular vesicles directly...
